EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential

Dominika Skarbek iD, Alicja Sochocka, Oliwia Sidło iD, Aleksandra Sapiaszko iD, Agnieszka Drab, Jacek Baj iD, Robert Rejdak, Joanna Dolar-Szczasny iD

Life · 13.05.2026 · 16 (5) · 810

DOI: 10.3390/life16050810 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Life, online erschienen am 13.05.2026. Verfasst von Dominika Skarbek und 7 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Posterior segment eye diseases, including age-related macular degeneration and diabetic retinopathy, are preeminent causes of vision loss worldwide. Effective drug delivery to the retina poses an ongoing therapeutic difficulty due to the presence of the anatomical and physiological barriers. Nanotechnology-based drug delivery systems represent a promising strategy to overcome those limitations.

Methods

A narrative literature review was conducted using the PubMed, Scopus, and Google Scholar databases, covering publications published between 2019 and 2026. Publications evaluating nanoparticles for the treatment of the vitreoretinal disorders, including pre-clinical in vitro and in vivo studies, were analyzed.

Results

Nanocarriers, including liposomes, polymeric nanoparticles, and lipid-based systems, established improved drug bioavailability, stability, and targeted delivery. The analyzed systems facilitate sustained drug release and potentially reduce the prevalence of invasive intravitreal injections. The nanocarriers’ effectiveness is primarily influenced by their physicochemical properties, such as particle size, surface charge, and encapsulation efficiency. Nonetheless, the production costs and safety aspects, including cytotoxicity, oxidative stress, and inflammatory responses, remain as significant limitations.

Conclusions

Nanotechnology-based drug delivery systems serve as an auspicious therapeutic approach for posterior segment eye diseases. However, further standardized preclinical and clinical research is required to assure long-term safety and enable successful clinical transition.

Schlagwörter

Stichwörter der Autor:innen

PLGAintravitreal deliveryliposomesnanocarriersocular drug deliverypolymeric nanoparticlesretinal diseasestargeted drug delivery

Autor:innen und Institutionen

  • Student Scientific Club at the Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1, 20-079 Lublin, Poland.
  • Department of Medical Informatics and Statistics with e-Health Lab, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.
  • Department of Correct, Clinical and Imaging Anatomy, Medical University of Lublin, Jaczewskiego 4, 20-090 Lublin, Poland.
  • Department of General and Paediatric Ophthalmology, Medical University of Lublin, Chmielna 1., 20-079 Lublin, Poland.

ORCID-Profile: Dominika Skarbek, Oliwia Sidło, Aleksandra Sapiaszko, Jacek Baj, Joanna Dolar-Szczasny

Zitieren

APA

Skarbek, D., Sochocka, A., Sidło, O., Sapiaszko, A., Drab, A., Baj, J., Rejdak, R., & Dolar-Szczasny, J. (2026). Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential. Life, 16(5), 810. https://doi.org/10.3390/life16050810

Vancouver

Skarbek D, Sochocka A, Sidło O, Sapiaszko A, Drab A, Baj J, et al. Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential. Life. 2026;16(5):810. doi:10.3390/life16050810

BibTeX
@article{Skarbek2026,
  author = {Skarbek, Dominika and Sochocka, Alicja and Sidło, Oliwia and Sapiaszko, Aleksandra and Drab, Agnieszka and Baj, Jacek and Rejdak, Robert and Dolar-Szczasny, Joanna},
  title = {Nanocarrier-Based Ocular Drug Delivery Systems for Retinal Diseases: Therapeutic Potential},
  journal = {Life},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {810},
  doi = {10.3390/life16050810}
}
Kostenlos starten →